TAGAMET HB

LOE Approaching

cimetidine

NDAORALTABLET
Approved
Jun 1995
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3

Mechanism of Action

Histamine H2 Receptor Antagonists

Pharmacologic Class:

Histamine-2 Receptor Antagonist

Clinical Trials (3)

NCT00800280Phase 1Terminated

Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body

Started Jan 2009
12 enrolled
Generalized Anxiety Disorder
NCT01366378Phase 1Completed

Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX

Started Jan 2007
18 enrolled
Healthy Adult Subjects
NCT02172417Phase 1Completed

Tiotropium in Combination With Concomitant Cimetidine or Ranitidine in Healthy Male and Female Subjects

Started Jul 2000
18 enrolled
Healthy
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers
Data Sources
  • Drug label: DailyMed / FDA
  • Clinical trials: ClinicalTrials.gov
  • Patent data: FDA Orange Book
  • Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.